, Inc.

4-19-2021 SmallCapVoice Interview with BriaCell Therapeutics Corp



AUSTIN, Texas (April XX, 2021) -- Inc. (“SCV”) announces the availability of a new interview with Bill Williams, M.D., president CEO of BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX-V: BCT) (“the Company”), to discuss the Company’s targeted immunotherapies for breast cancer and its unique position as a clinical-stage biotech with proof-of-concept data for its lead asset. BriaCell develops novel therapies for the safe and targeted management of cancer. Speaking with SCV’s Stuart Smith, Dr. Williams discusses BriaCell’s drug pipeline, highlighting lead candidate Bria-IMT™ for advanced breast cancer. As the second-leading cause of cancer in women, breast cancer kills 43,000 women in the U.S. each year. With Bria-IMT, BriaCell sees the potential to change these statistics; Bria-IMT has achieved positive proof-of-concept (POC) in three clinical trials, where it improved the survival rate of women with advanced-stage breast cancer by over a year. While the positive data was an obvious win